Delivery Order SPE2DB22D2206-SPE2DB24FKJ67

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,474.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication FYCOMPA 2 MG TABLET 30S, with an ultimate completion date of April 17, 2025. The contract is a firm fixed-price, non-set-aside award. Additionally, Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of FYCOMPA 4 MG TABLET 30S pharmaceutical products to the Defense Logistics Agency (DLA). The award, valued at $1,474.35, was issued on August 26, 2022 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., as the prime contractor. The contract has a performance period through August 29, 2022 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,611.96, is for the delivery of the prescription drug FYCOMPA 2 MG Tablet 30S. The contract is a Firm Fixed Price Delivery Order, with a completion date of May 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,815.70 firm fixed-price delivery order is for the supply of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,421.01 delivery order contract is for the supply of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) arrangement with a completion date of November 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $4,135.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania. The award is for the delivery of the pharmaceutical product FYCOMPA 8 MG TABLET 30S, a firm fixed price delivery order with a performance period through March 22, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen...
This federal contract award, valued at $1,027.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product FYCOMPA 8 MG TABLET 30S, with an ultimate completion date of April 1, 2025. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,027.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with an ultimate completion date of March 10, 2025. The contract covers the procurement of FYCOMPA 8 MG TABLET 30S, a pharmaceutical product, for the DLA. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.56 contract is for the supply of FYCOMPA 4 MG TABLET 30S, a prescription medication. The contract has a firm fixed price pricing type and a completion date of July 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,394.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of the pharmaceutical product FYCOMPA 4 MG TABLET 30S, a medication likely used to treat various medical conditions. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of March 2, 2023. It is not designated as a set-aside contract,...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKJ67
    Delivery Order

This federal contract award, valued at $3,575.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of FYCOMPA 4 MG TABLET 30S, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of September 17, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award. The company has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, collectively valued at up to $999,999,999, to provide a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives.

Generated 12/16/24, 2:23 PM